CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor

Clinical trial NCT02617134 · UNKNOWN

Trial details

NCT number: NCT02617134
Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Glioma of Brain Colorectal Carcinoma Gastric Carcinoma

Start date: 2015-11-01
Primary completion: 2017-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.